Superluminal Medicines (Series A)

Funding Details
Awarder
Inbox
Date Award
June 09, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$120,000,000

Company Info
Organizations Involved
NVIDIA, Eli Lilly and Company
Company Description
Superluminal Medicines, Inc., 'The Membrane Company' using generative biology, chemistry, and machine learning approaches to revolutionize the speed and accuracy of how medicines are created.
Market
Pharmaceuticals
Location
Boston, MA, USA
Coinvestors
Insight Partners, NVentures, Gaingels, Catalio Capital Management, Eli Lilly and Company, Cooley LLP

Links